GNQ Insilico plans to accelerate the adoption of precision medicine and clinical AI in drug development and patient care
By Business Wire Publication Date: 2026-04-15 21:25:00 The new service offering combines GNQ Insilico’s Causal AI Drug Assessment, Drug Simulation…